webinar register page

Webinar banner
MSGERC Grand Rounds Webinar Series, Episode 3— Invasive Mold Infections: Addressing Emerging Resistance
Join us for the third live MSGERC Grand Rounds virtual webinar. In this episode, Drs Nathan Wiederhold, Thomas Patterson, and Jeremy Gold discuss various aspects of management of invasive mold infections, including risk-factor assessment, diagnosis, antifungal susceptibility testing, and treatment. The faculty will discuss cases of Aspergillus and non-Aspergillus molds, including resistant dermatophyte infections. The webinar will feature many opportunities to interact in the discussion of these challenging infections.

This educational initiative was funded in part by a cooperative agreement with the Centers for Disease Control and Prevention (CDC-RFA-CK20-2003) to the University of Alabama at Birmingham. The University of Alabama at Birmingham is collaborating with the Mycoses Study Group Education & Research Consortium and Terranova Medica, LLC, on this initiative. The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this resource center do not necessarily represent the policy of CDC or HHS and should not be considered an endorsement by the Federal Government.

Aug 30, 2022 01:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information


Nathan P. Wiederhold, PharmD
Professor- Director Fungus, Testing Laboratory, UT Health San Antonio @Joe R. & Teresa Lozano Long School of Medicine, San Antonio, Texas
Dr. Wiederhold’s research is focused on trends in antifungal resistance, new mechanisms of drug resistance in fungi, and the evaluation of novel agents under development for the treatment of invasive fungal infections. The Fungus Testing Laboratory is an international reference mycology laboratory with both clinical and research missions. The lab’s research focuses on the preclinical evaluation of investigational therapeutic modalities and diagnostic technologies for the diagnosis and treatment of fungal infections. This includes both in vitro assessment for activity against a wide range of fungal pathogens, including multi-drug resistant clinical isolates, and in vivo models of invasive fungal infections. This work is supported through NIH/NIAID contracts and grants from industry, and the lab collaborates closely with other researchers in the Departments of Microbiology and Immunology, Medicine/Infectious Diseases, and Pathology in these studies.
Thomas F Patterson, MD
Chief Division of Infectious Diseases, Vice Chair, Faculty Development, Professor of Medicine, UT Health San Antonio @Joe R. & Teresa Lozano Long School of Medicine, San Antonio, Texas
Dr Patterson received his BA degree from Baylor University, in Waco, Texas and his medical degree from the University of Texas Medical School at Houston, Texas. He completed his internship and residency at Vanderbilt University Medical School, in Nashville, TN and at Yale-New Haven Hospital, and his fellowship in infectious diseases at Yale University School of Medicine, New Haven, Connecticut, where he also served as an Assistant Professor of Medicine. Dr Patterson currently is a Professor of Medicine and Chief, Division of Infectious Diseases at the University of Texas Health Science Center in San Antonio, Texas. He is also Director of the San Antonio Center for Medical Mycology. He has extensive experience in opportunistic fungal infections. His clinical and research interests focus on the diagnosis and treatment of fungal diseases, particularly in immunocompromised hosts. He has been involved in developing new antifungal drugs and in clinical trials of new antifungal compounds.
Jeremy Gold, MD, MS
Medical Officer @Centers for Disease Control and Prevention, Atlanta, Georgia
Jeremy Gold, MD, MS, is a medical officer with the Mycotic Diseases Branch at the US Centers for Disease Control and Prevention. He earned his Bachelor of Science degree in Biology at McGill University (2011) and his Master of Science and medical degrees from Albert Einstein College of Medicine (2016). He completed his internal medicine internship and residency at Columbia University Irving Medical Center (2019). His main research interests are invasive mold disease and antifungal-resistant infections.